Table 3.
Mortality(%)b | SMR | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Na | 1-year | 2-year | 3-year | 5-year | 10-year | 1-year | 2-year | 3-year | 5-year | 10-year | ||
Total | ||||||||||||
Total | 4,523 | 1.28 | 2.44 | 3.54 | 5.32 | 10.50 | 8.33 | 7.59 | 7.28 | 6.39 | 5.82 | |
Male | 3,439 | 1.45 | 2.69 | 3.98 | 6.13 | 12.02 | 7.82 | 6.91 | 6.83 | 6.13 | 5.54 | |
Female | 1,084 | 0.74 | 1.65 | 2.13 | 2.69 | 5.32 | 12.90 | 13.57 | 11.24 | 8.66 | 8.20 | |
20–24 years | ||||||||||||
Total | 961 | 0.21 | 0.62 | 1.05 | 1.63 | 2.32 | 2.75 | 4.17 | 4.30 | 3.49 | 3.42 | |
Male | 687 | 0.14 | 0.58 | 1.03 | 1.83 | 2.09 | 0.00 | 2.46 | 2.81 | 2.61 | 2.29 | |
Female | 274 | 0.36 | 0.73 | 1.09 | 1.09 | 2.96 | 18.05 | 13.69 | 12.67 | 8.52 | 9.95 | |
25–29 years | ||||||||||||
Total | 959 | 0.93 | 1.24 | 1.93 | 3.51 | 9.27 | 7.66 | 5.27 | 5.60 | 6.09 | 5.26 | |
Male | 723 | 1.10 | 1.24 | 2.14 | 3.89 | 10.27 | 7.53 | 4.31 | 5.19 | 5.62 | 4.95 | |
Female | 236 | 0.42 | 1.26 | 1.26 | 2.33 | 5.96 | 8.68 | 13.00 | 8.93 | 9.89 | 7.79 | |
30–34 years | ||||||||||||
Total | 1,075 | 1.48 | 2.96 | 4.05 | 5.58 | 11.86 | 10.15 | 9.54 | 8.33 | 6.94 | 6.35 | |
Male | 846 | 1.53 | 3.29 | 4.41 | 5.93 | 13.05 | 9.17 | 9.16 | 8.02 | 6.58 | 5.98 | |
Female | 229 | 1.31 | 1.75 | 2.67 | 4.30 | 4.30 | 20.32 | 13.50 | 11.62 | 10.73 | 10.16 | |
35–39 years | ||||||||||||
Total | 1,528 | 2.02 | 3.97 | 5.76 | 8.56 | 15.53 | 8.84 | 8.07 | 7.90 | 6.80 | 6.22 | |
Male | 1,183 | 2.35 | 4.37 | 6.51 | 10.13 | 18.29 | 8.80 | 7.46 | 7.53 | 6.74 | 6.13 | |
Female | 345 | 0.86 | 2.59 | 3.18 | 3.18 | 6.17 | 9.26 | 13.77 | 11.42 | 7.39 | 6.94 |
aThe N represents the number of young adults with hip fracture enrollerd initially in the study
bThe follow-up mortality rates were estimated using Kaplan–Meier (KM) method